New study tests ways to keep young women HIV-Free
NCT ID NCT04038060
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at different ways to help young women in South Africa, ages 18-25, take their daily HIV prevention pill (PrEP) consistently. The goal was to find the best support strategies to keep them protected from HIV. 360 women took part in the study, which tested a step-by-step approach to see which support methods worked best.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wits Reproductive Health and HIV Institute
Johannesburg, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could routine STI screening during pregnancy prevent preterm births?
- Could HIV and age weaken vaccine protection? study investigates
- Can facebook help prevent HIV in rural appalachia?
- Could giving TB pills on day one save more lives?
- Massive brazilian registry aims to uncover hidden health risks in HIV patients
- Clinic culture change aims to boost HIV outcomes for black patients